सत्याधीशसत्याधीश
SatyaDheesh
India's Ground Truth Record
Pull to refresh
VOL. I · EST. 11.2025 
SatyaDheesh
सत्याधीश
India's Ground Truth Record
LIVE

Study attempts to find out how India made expensive diabetes medicines affordable

GS2Polity · Governance · IR· Health policy & public health· Prelims + Mains·

Pharmaceutical model for chronic disease management: a GS2 Social Justice and healthcare accessibility case study.

Why in news

A study led by V. Mohan, chairman of Dr. Mohan’s Diabetes Specialities Centre, examined India's model for making expensive diabetes medicines affordable for low- and middle-income countries (LMICs).

Background

The study, published in 'Diabetes Care' on September 19, 2026, highlights that 80% of the 589 million adults with diabetes globally reside in LMICs. It focuses on making modern therapies like GLP-1 receptor agonists, SGLT2i, and analogue insulins accessible.

Facts for Prelims

  • S&TGLP-1 receptor agonists and SGLT2i are identified as modern therapies for diabetes.
  • Fact80% of the 589 million adults with diabetes globally reside in low- and middle-income countries (LMICs).
  • PostV. Mohan is the chairman of Dr. Mohan’s Diabetes Specialities Centre in Chennai.

Prelims practice question

What percentage of the 589 million adults with diabetes globally reside in low- and middle-income countries (LMICs)?

  1. (a)90%
  2. (b)75%
  3. (c)80%
  4. (d)60%
Show answer

Answer: (c) 80% — The study highlights that 80% of the 589 million adults with diabetes globally reside in LMICs.

For Mains

Q. Discuss how India's pharmaceutical model for affordable healthcare can serve as a blueprint for low- and middle-income countries to manage chronic diseases.

Dimensions to cover in your answer

  • Cost-accessibility trade-off: Balancing the high R&D costs of modern therapies like GLP-1 agonists with the need for affordable generic alternatives.
  • LMIC healthcare burden: Addressing the financial constraints of lifelong care for 80% of the global diabetic population.

Keywords: Affordability · Pharmaceutical Model · LMICs · Chronic Disease Management · Healthcare Accessibility

Read the full news →Report a mistake in this noteSource: The Hindu ↗

More Social Justice notes

All Social Justice current affairs →

Something wrong, or something missing?

Spotted a mistake in a note, or want a topic, format or PDF that would help your preparation? Write to us. We read every mail and fix errors fast.

Report a mistake →Ask for something →[email protected]

This note is generated automatically from SatyaDheesh's news feed and mapped to the UPSC CSE syllabus. Check facts against the original report or PIB before using them in an answer.